Literature DB >> 12898156

Neuropathological analysis in spinal muscular atrophy type II.

S Araki1, M Hayashi, K Tamagawa, M Saito, S Kato, T Komori, Y Sakakihara, T Mizutani, M Oda.   

Abstract

We performed a neuropathological analysis, including in situ nick end labeling (ISEL) and immunohistochemistry, of two cases of clinicogenetically confirmed infantile spinal muscular atrophy (SMA) type II. Both cases showed severe reduction of the motor neurons and gliosis in the spinal cord and brain stem, although the occurrences of central chromatolysis and ballooned neurons were not frequent. Clark's and lateral thalamic nuclei, which are usually altered in SMA type I, were spared, whereas Betz cells in the precentral gyrus and large myelinated fibers in the lateral funiculus were reduced in number. Regarding apoptosis, only the younger case demonstrated a few ISEL-positive nuclei in the dorsal horn, with reduced Bcl-x expression level in the Purkinje cells. Unlike SMA type I, the expression of neurofilaments was not disturbed and the reduction in synaptophysin expression level in the anterior horn was mild. An oxidative stress-related product was deposited in atrophic motor neurons in the spinal cord, and neurons with nuclei immunoreactive for 8-hydroxy-2'-deoxyguanosine were found in the lateral thalamus. In contrast, the expression of glial glutamate transporters was not altered. These data suggest that oxidative stress and, to a lesser extent, apoptotic cell death, but not disturbed neurofilament metabolism or excitotoxicity, may be involved in neurodegeneration in SMA type II.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898156     DOI: 10.1007/s00401-003-0743-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  Failure of lower motor neuron radial outgrowth precedes retrograde degeneration in a feline model of spinal muscular atrophy.

Authors:  Erin N Wakeling; Béatrice Joussemet; Patrick Costiou; Dominique Fanuel; Philippe Moullier; Martine Barkats; John C Fyfe
Journal:  J Comp Neurol       Date:  2012-06-01       Impact factor: 3.215

Review 2.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

Review 3.  Inflammation in ALS and SMA: sorting out the good from the evil.

Authors:  Dimitra Papadimitriou; Virginia Le Verche; Arnaud Jacquier; Burcin Ikiz; Serge Przedborski; Diane B Re
Journal:  Neurobiol Dis       Date:  2009-10-13       Impact factor: 5.996

Review 4.  Spinal Muscular Atrophy.

Authors:  Stephen J Kolb; John T Kissel
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

Review 5.  Spinal muscular atrophy: diagnosis and management in a new therapeutic era.

Authors:  W David Arnold; Darine Kassar; John T Kissel
Journal:  Muscle Nerve       Date:  2014-12-16       Impact factor: 3.217

6.  SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.

Authors:  Thomas M Wishart; Jack P-W Huang; Lyndsay M Murray; Douglas J Lamont; Chantal A Mutsaers; Jenny Ross; Pascal Geldsetzer; Olaf Ansorge; Kevin Talbot; Simon H Parson; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2010-08-12       Impact factor: 6.150

7.  Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion.

Authors:  Jasmin E Martin; TrangKimberly T Nguyen; Christopher Grunseich; Jonathan H Nofziger; Philip R Lee; Douglas Fields; Kenneth H Fischbeck; Emily Foran
Journal:  J Neurosci       Date:  2017-04-27       Impact factor: 6.167

8.  Entity/quality-based logical definitions for the human skeletal phenome using PATO.

Authors:  Georgios V Gkoutos; Chris Mungall; Sandra Dolken; Michael Ashburner; Suzanna Lewis; John Hancock; Paul Schofield; Sebastian Kohler; Peter N Robinson
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

9.  Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.

Authors:  Li-Kai Tsai; Ming-Shiun Tsai; Chen-Hung Ting; Hung Li
Journal:  J Mol Med (Berl)       Date:  2008-07-23       Impact factor: 4.599

Review 10.  Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis.

Authors:  Emily Foran; Davide Trotti
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.